By Professor Elgene Lim

Conference Posters

Turner NC; Loi S; Moore HM; Chang C-W; Eng-Wong J; Bardia A; Boni V; Sohn J; Jhaveri KL; Lim E, 2022, 'Abstract PD13-07: Activity and biomarker analyses from a phase Ia/b study of giredestrant (GDC-9545; G) with or without palbociclib (palbo) in patients with estrogen receptor-positive, HER2-negative locally advanced/metastatic breast cancer (ER+/HER2- LA/mBC)', Vol. 82, http://dx.doi.org/10.1158/1538-7445.sabcs21-pd13-07

Back to profile page